Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Marlies Keijzers, Jan Damoiseaux, Alain Vigneron, Nicolas Bodart, Alfons Kessels, Anne-Marie C. Dingemans, Monique Hochstenbag, Jos Maessen & Marc De Baets. (2015) Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?. Autoimmunity 48:8, pages 552-555.
Read now
Read now
Mahdi Alahgholi-Hajibehzad, Pinar Kasapoglu, Reza Jafari & Nima Rezaei. (2015) The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics. Expert Review of Clinical Immunology 11:7, pages 859-870.
Read now
Read now
Jie Luo & Jon Lindstrom. (2012) Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors. Autoimmunity 45:3, pages 245-252.
Read now
Read now
Marc H. De Baets. (2010) Insights in the autoimmunity of myasthenia gravis. Autoimmunity 43:5-6, pages 341-343.
Read now
Read now
Rozen Le Panse, Jacky Bismuth, Géraldine Cizeron-Clairac, Julia Miriam Weiss, Perrine Cufi, Philippe Dartevelle, Nicole Kerlero De Rosbo & Sonia Berrih-Aknin. (2010) Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity 43:5-6, pages 401-412.
Read now
Read now
Alejandro M. Gomez, Joost Van Den Broeck, Kathleen Vrolix, Sofie P. Janssen, Marijke A. M. Lemmens, Eline Van Der Esch, Hans Duimel, Peter Frederik, Peter C. Molenaar, Pilar Martínez-Martínez, Marc H. De Baets & Mario Losen. (2010) Antibody effector mechanisms in myasthenia gravis—Pathogenesis at the neuromuscular junction. Autoimmunity 43:5-6, pages 353-370.
Read now
Read now
A. Marx, N. Willcox, M. I. Leite, W.-Y. Chuang, B. Schalke, W. Nix & P. Ströbel. (2010) Thymoma and paraneoplastic myasthenia gravis. Autoimmunity 43:5-6, pages 413-427.
Read now
Read now
Articles from other publishers (37)
Christos Stergiou, Rhys Williams, Jennifer R. Fleming, Vasiliki Zouvelou, Elpinickie Ninou, Francesca Andreetta, Elena Rinaldi, Ornella Simoncini, Renato Mantegazza, Julius Bogomolovas, John Tzartos, Siegfried Labeit, Olga Mayans & Socrates Tzartos. (2023) Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis. Biomedicines 11:2, pages 449.
Crossref
Crossref
Sampita Pal, Hasham S. Sofi, Lubna Azmi, Nisar Ahmad Khan, Shafquat Majeed, Mushtaq A. Beigh & Faheem A. Sheikh. 2023. Interaction of Nanomaterials With Living Cells. Interaction of Nanomaterials With Living Cells
1
28
.
Meropi Karakioulaki, Dedee F. Murrell, Aikaterini Kyriakou & Aikaterini Patsatsi. (2022) Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications. International Journal of Women’s Dermatology 8:3, pages e053.
Crossref
Crossref
Kalaivani Manibarathi, Chit Tong Lio & Tanima Bose. 2022. Translational Autoimmunity. Translational Autoimmunity
231
260
.
Naeemeh Khalesi, Shahla Korani, Mitra Korani, Thomas P. Johnston & Amirhossein Sahebkar. (2021) Bortezomib: a proteasome inhibitor for the treatment of autoimmune diseases. Inflammopharmacology 29:5, pages 1291-1306.
Crossref
Crossref
Ann P. Murchison, Jurij R. Bilyk & Peter J. Savino. 2021. Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery. Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery
243
278
.
Esther M. Vletter, Marvyn T. Koning, Hans Ulrich Scherer, Hendrik Veelken & Rene E. M. Toes. (2020) A Comparison of Immunoglobulin Variable Region N-Linked Glycosylation in Healthy Donors, Autoimmune Disease and Lymphoma. Frontiers in Immunology 11.
Crossref
Crossref
Luca Antonioli, Corrado Blandizzi, Pál Pacher & György Haskó. (2019) The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases. Pharmacological Reviews 71:3, pages 345-382.
Crossref
Crossref
Muriel Sudres, Marie Maurer, Marieke Robinet, Jacky Bismuth, Frédérique Truffault, Diane Girard, Nadine Dragin, Mohamed Attia, Elie Fadel, Nicola Santelmo, Camille Sicsic, Talma Brenner & Sonia Berrih-Aknin. (2017) Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model. JCI Insight 2:7.
Crossref
Crossref
Håvard Torvik Gotaas, Geir Olve Skeie & Nils Erik Gilhus. (2016) Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap. Neuromuscular Disorders 26:6, pages 337-341.
Crossref
Crossref
Jamal S Lewis & Riley P Allen. (2016) An introduction to biomaterial-based strategies for curbing autoimmunity. Experimental Biology and Medicine 241:10, pages 1107-1115.
Crossref
Crossref
C. Stergiou, K. Lazaridis, V. Zouvelou, J. Tzartos, R. Mantegazza, C. Antozzi, F. Andreetta, A. Evoli, F. Deymeer, G. Saruhan-Direskeneli, H. Durmus, T. Brenner, A. Vaknin, S. Berrih-Aknin, A. Behin, T. Sharshar, M. De Baets, M. Losen, P. Martinez-Martinez, K.A. Kleopa, E. Zamba-Papanicolaou, T. Kyriakides, A. Kostera-Pruszczyk, P. Szczudlik, B. Szyluk, D. Lavrnic, I. Basta, S. Peric, C. Tallaksen, A. Maniaol, N.E. Gilhus, C. Casasnovas Pons, J. Pitha, M. Jakubíkova, F. Hanisch, J. Bogomolovas, D. Labeit, S. Labeit & S.J. Tzartos. (2016) Titin antibodies in “seronegative” myasthenia gravis — A new role for an old antigen. Journal of Neuroimmunology 292, pages 108-115.
Crossref
Crossref
Chen Ying, Wang Li, Zhou Li & Gao Ying. (2016) Ocular myasthenia gravis accompanied by anosmia. Journal of Traditional Chinese Medicine 36:1, pages 125-130.
Crossref
Crossref
Iñaki Alvarez, Javier A. Collado, Roger Colobran, Montserrat Carrascal, M. Teresa Ciudad, Françesc Canals, Eddie A. James, William W. Kwok, Martina Gärtner, Bruno Kyewski, Ricardo Pujol-Borrell & Dolores Jaraquemada. (2015) Central T cell tolerance: Identification of tissue-restricted autoantigens in the thymus HLA-DR peptidome. Journal of Autoimmunity 60, pages 12-19.
Crossref
Crossref
R. Wang, J. Li, M. Wang, H. Hao, X. Chen, R. Li & X. Zhu. (2015) Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis. British Journal of Dermatology 172:4, pages 968-975.
Crossref
Crossref
Zsuzsanna Pal, László Tóthfalusi, Zsolt Lörincz, Bence György, Maria Judit Molnar, Andras Falus & Edit I. Buzás. (2014) Immunosuppressants increase the levels of natural autoantibodies reactive with glycosaminoglycans in myasthenia gravis. Journal of Neuroimmunology 276:1-2, pages 224-228.
Crossref
Crossref
Anette S. B. Wolff, Jaanika Kärner, Jone F. Owe, Bergithe E. V. Oftedal, Nils Erik Gilhus, Martina M. Erichsen, Olle Kämpe, Anthony Meager, Pärt Peterson, Kai Kisand, Nick Willcox & Eystein S. Husebye. (2014) Clinical and Serologic Parallels to APS-I in Patients with Thymomas and Autoantigen Transcripts in Their Tumors. The Journal of Immunology 193:8, pages 3880-3890.
Crossref
Crossref
Perrine Cufi, Patrick Soussan, Frédérique Truffault, Rachid Fetouchi, Marieke Robinet, Elie Fadel, Sonia Berrih-Aknin & Rozen Le Panse. (2014) Thymoma-associated myasthenia gravis: On the search for a pathogen signature. Journal of Autoimmunity 52, pages 29-35.
Crossref
Crossref
Perrine Cufi, Nadine Dragin, Nathalie Ruhlmann, Julia Miriam Weiss, Elie Fadel, Alain Serraf, Sonia Berrih-Aknin & Rozen Le Panse. (2014) Central role of interferon-beta in thymic events leading to myasthenia gravis. Journal of Autoimmunity 52, pages 44-52.
Crossref
Crossref
Kathleen Vrolix, Judith Fraussen, Mario Losen, Jo Stevens, Konstantinos Lazaridis, Peter C. Molenaar, Veerle Somers, Maria Alma Bracho, Rozen Le Panse, Piet Stinissen, Sonia Berrih-Aknin, Jos G. Maessen, Leen Van Garsse, Wim A. Buurman, Socrates J. Tzartos, Marc H. De Baets & Pilar Martinez-Martinez. (2014) Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor. Journal of Autoimmunity 52, pages 101-112.
Crossref
Crossref
Christian Probst, Sandra Saschenbrecker, Winfried Stoecker & Lars Komorowski. (2014) Anti-neuronal autoantibodies: Current diagnostic challenges. Multiple Sclerosis and Related Disorders 3:3, pages 303-320.
Crossref
Crossref
Luis Querol & Isabel Illa. (2013) Myasthenia gravis and the neuromuscular junction. Current Opinion in Neurology 26:5, pages 459-465.
Crossref
Crossref
Reinhild Klein, Alexander Marx, Philipp Ströbel, Berthold Schalke, Wilfred Nix & Nick Willcox. (2013) Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis. Human Immunology 74:9, pages 1184-1193.
Crossref
Crossref
Judith Fraussen, Kathleen Vrolix, Nele Claes, Pilar Martinez-Martinez, Mario Losen, Raymond Hupperts, Bart Van Wijmeersch, Mercedes Espiño, Luisa M. Villar, Marc H. De Baets, Piet Stinissen & Veerle Somers. (2013) Autoantigen induced clonal expansion in immortalized B cells from the peripheral blood of multiple sclerosis patients. Journal of Neuroimmunology 261:1-2, pages 98-107.
Crossref
Crossref
Jan J.G.M. Verschuuren, Maartje G. Huijbers, Jaap J. Plomp, Erik H. Niks, Peter C. Molenaar, Pilar Martinez-Martinez, Alejandro M. Gomez, Marc H. De Baets & Mario Losen. (2013) Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4. Autoimmunity Reviews 12:9, pages 918-923.
Crossref
Crossref
GZ Huang & YL Lo. (2013) Correlation Between Acetylcholine Receptor Antibody Levels and Thymic Pathology in Myasthenia Gravis. Journal of Clinical Neuromuscular Disease 14:4, pages 209-217.
Crossref
Crossref
Anne Becker, Nicole Ludwig, Andreas Keller, Björn Tackenberg, Christian Eienbröker, Wolfgang H. Oertel, Klaus Fassbender, Eckart Meese & Klemens Ruprecht. (2013) Myasthenia Gravis: Analysis of Serum Autoantibody Reactivities to 1827 Potential Human Autoantigens by Protein Macroarrays. PLoS ONE 8:3, pages e58095.
Crossref
Crossref
Lucienne Chatenoud. (2013) Diagnostic d’une maladie auto-immune. Revue Francophone des Laboratoires 2013:449, pages 28-29.
Crossref
Crossref
Perrine Cufi, Nadine Dragin, Julia Miriam Weiss, Pilar Martinez‐Martinez, Marc H. De Baets, Régine Roussin, Elie Fadel, Sonia Berrih‐Aknin & Rozen Le Panse. (2012) Implication of double‐stranded RNA signaling in the etiology of autoimmune myasthenia gravis. Annals of Neurology 73:2, pages 281-293.
Crossref
Crossref
Muthusamy Thiruppathi, Julie Rowin, Balaji Ganesh, Jian Rong Sheng, Bellur S. Prabhakar & Matthew N. Meriggioli. (2012) Impaired regulatory function in circulating CD4+CD25highCD127low/− T cells in patients with myasthenia gravis. Clinical Immunology 145:3, pages 209-223.
Crossref
Crossref
Lydia Sharp & Steven Vernino. (2012) Paraneoplastic neuromuscular disorders. Muscle & Nerve 46:6, pages 839-840.
Crossref
Crossref
Ann P. Murchison, Jurij R. Bilyk & Peter J. Savino. 2012. Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery. Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery
361
392
.
Zsuzsanna Pál, Judit Boczán, Benjamin Bereznai, Gábor Lovas & Mária Judit Molnár. (2011) Treatment of anti-MuSK antibody positive myasthenia gravis. Orvosi Hetilap 152:39, pages 1586-1589.
Crossref
Crossref
Roger John Willis Truscott. (2011) Macromolecular deterioration as the ultimate constraint on human lifespan. Ageing Research Reviews 10:4, pages 397-403.
Crossref
Crossref
Alejandro M. Gomez, Kathleen Vrolix, Pilar Martínez-Martínez, Peter C. Molenaar, Marko Phernambucq, Eline van der Esch, Hans Duimel, Fons Verheyen, Reinhard E. Voll, Rudolf A. Manz, Marc H. De Baets & Mario Losen. (2011) Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis. The Journal of Immunology 186:4, pages 2503-2513.
Crossref
Crossref
Jozsef Pal, Csilla Rozsa, Samuel Komoly & Zsolt Illes. (2011) Clinical and biological heterogeneity of autoimmune myasthenia gravis. Journal of Neuroimmunology 231:1-2, pages 43-54.
Crossref
Crossref
J. Fraussen, K. Vrolix, P. Martinez-Martinez, M. Losen, E. Meulemans, M.H. De Baets, P. Stinissen & V. Somers. (2010) A novel method for making human monoclonal antibodies. Journal of Autoimmunity 35:2, pages 130-134.
Crossref
Crossref